English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, December 19, 2019
Viva Biotech Was Included as a Constituent Stock of the Hang Seng Hong Kong-Listed Biotech Index
Monday, October 14, 2019
Cheney Mao - Chairman & CEO, Viva Biotech, China
Friday, August 30, 2019
摩通看好維亞生物 目標價5.5港元
Thursday, August 22, 2019
安捷证券:首次覆盖维亚生物 (1873.HK)给予买入评级,目标价5.03港元
安捷證券:首次覆蓋維亞生物 (1873.HK)給予買入評級,目標價5.03港元
Wednesday, July 3, 2019
維亞生物孵化企業Dogma揭秘首創口服PCSK9抑制劑研發項目
Thursday, April 25, 2019
维亚生物宣布于港交所主板上市计划
維亞生物宣佈於港交所主板上市計劃
Viva Biotech Announces Proposed Listing on the Main Board of SEHK

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575